Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Velan Inc T.VLN

Alternate Symbol(s):  VLNSF

Velan Inc. is a Canada-based manufacturers of industrial valves. The Company designs, manufactures and markets a range of industrial valves for use in industry applications, including power generation, oil and gas, refining and petrochemicals, chemicals, liquid natural gas and cryogenics, pulp and paper, geothermal processes and shipbuilding. Its products include Quarter-turn valves, Gate, globe, and check valves, Cryogenic valves, HF Acid valves, Steam traps, Bellows seal valves and Velan ABV Valves. Its services include research and development, maintenance manuals (IOMs), spare parts and service locations. The North American operations comprising two manufacturing plants in Canada, as well as one manufacturing plant and one distribution facility in the United States. Its overseas operations include manufacturing plants in France, Italy, Portugal, Korea, Taiwan, India, and China. The Company’s operations also include a sales operation in Germany.


TSX:VLN - Post by User

Comment by screamer99on Jan 15, 2024 10:05am
213 Views
Post# 35826742

RE:Results

RE:ResultsTotal customer deposits is $62m. Total cash is $30m which means the company spent $32m in cash received from customers for product that hasn't yet been delivered to them. If the cash hasn't already been reinvested in inventory, this is a sign of worse things to come.

A ray of light is in the bookings due to be billed in the next 12 months. This is a healthy number, but the company continues to have the asbestos monkey on their back.

It's a shame investors (I'm not one of them) will need to wait quite a while for year end results, but the next 12 months will be interesting.

Quarterly revenues need to be at least $90m for this valuation to hold up. Maybe more with declining gross margin.
<< Previous
Bullboard Posts
Next >>